Since the lung is considered one of the primary target locations of SARS-CoV-2, it is argued that TMPRSS2 expression levels in pulmonary cells change across different populations, with consequent variable susceptibility to COVID-19. This evidence concerns the gene TMPRSS2 and COVID-19.